Safety, tolerability and pharmacokinetics of fesoterodine in patients with hepatic impairment
Sachse R1, Krastev Z2, Mateva L2, Gatchev E3, de Mey C4, Cawello W1, Horstmann R1 1. Department of Clinical Pharmacology, Schwarz Biosciences, Monheim, Germany, 2. Department Hepatology, Sofia University, Bulgaria, 3. Department Clinical Pharmacology, Sofia University, Bulgaria, 4. ACPS, Mainz-Kastel, Germany
|
Abstract 585
|
|
Read By Title:
Scientific Non Discussion Abstract Session 21
|
|